Merck and Ridgeback Biotherapeutics Covid-19 pill less effective
Merck has shared these additional analyses with the FDA and they will be presented to the FDA’s Antimicrobial Drugs Advisory Committee on Nov. 30th
Merck has shared these additional analyses with the FDA and they will be presented to the FDA’s Antimicrobial Drugs Advisory Committee on Nov. 30th
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
Owkin builds best-in-class predictive biomedical AI models and robust data sets
The company is marketing the kit under the brand name CoviFind and it can detect the infection in 15 minutes
An effectiveness result of 50 per cent achieved during the peak delta variant Covid-19 wave in India, in a highrisk study population of physicians and healthcare workers, in a hospital environment, provides insights into the efficacy and effectiveness of Covaxin
The main objective of successive rounds of the NFHS is to provide reliable and comparable data relating to health and family welfare and other emerging issues
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
A first for the Asian market, addressing the health spends needs of over 200 million households.
Officials from ACG signed the MoU with the Maharashtra government for the Rs 600 crore investment in the backward region of Marathwada
Subscribe To Our Newsletter & Stay Updated